Position in NUVB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,529,073
+$510,186 QoQ
Shares Held
269,203
+13.3% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 242 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. NUVB ranks #112 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,019,315 | $1,499,784,339 | |
| 2 | ARGX |
Argenx SE
|
395,661 | $367,082,405 | |
| 3 | GMAB |
Genmab A/S
|
8,644,877 | $237,474,771 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292,338 | $182,284,436 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,002,026 | $141,443,136 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,696,538 | $132,788,029 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
981,521 | $112,551,013 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,453,504 | $108,256,977 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,529,073 | 269,203 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,018,887 | 237,503 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,052,637 | 229,089 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $771,779 | 208,589 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $384,908 | 197,389 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $347,404 | 197,389 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $525,054 | 197,389 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $452,020 | 197,389 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $576,375 | 197,389 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $699,622 | 192,204 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $301,673 | 199,784 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $271,730 | 202,784 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $354,985 | 197,214 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $299,122 | 180,194 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $336,756 | 175,394 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $365,106 | 162,994 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $528,100 | 162,994 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $857,348 | 162,994 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,455,149 | 171,194 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $497,994 | 50,100 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $504,602 | 54,200 | Shares | Defined | 2021-07-30 | |
| No filing history on record for this holder in this stock. | ||||||